Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
申请人:Bradley Edward Stuart
公开号:US20050261272A1
公开(公告)日:2005-11-24
Compounds represented by Formula (I):
or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, and as cardioprotectants.
PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDE INHIBITORS OF GLYCOGEN PHOSPHORYLASE
申请人:Bradley Edward Stuart
公开号:US20070244090A9
公开(公告)日:2007-10-18
Compounds represented by Formula (I):
or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, and as cardioprotectants.